Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2018 - 2025)
Whitehawk Therapeutics (WHWK) has disclosed Other Working Capital Changes for 8 consecutive years, with $148000.0 as the latest value for Q3 2025.
- On a quarterly basis, Other Working Capital Changes rose 214.73% to $148000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$70000.0, a 98.06% increase, with the full-year FY2024 number at -$512000.0, up 85.79% from a year prior.
- Other Working Capital Changes was $148000.0 for Q3 2025 at Whitehawk Therapeutics, down from $676000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.1 million in Q3 2022 to a low of -$3.2 million in Q4 2023.
- A 5-year average of -$235578.9 and a median of -$124000.0 in 2023 define the central range for Other Working Capital Changes.
- Biggest YoY gain for Other Working Capital Changes was 654.76% in 2024; the steepest drop was 668.55% in 2024.
- Whitehawk Therapeutics' Other Working Capital Changes stood at -$655000.0 in 2021, then crashed by 185.34% to -$1.9 million in 2022, then plummeted by 72.71% to -$3.2 million in 2023, then skyrocketed by 96.0% to -$129000.0 in 2024, then skyrocketed by 214.73% to $148000.0 in 2025.
- Per Business Quant, the three most recent readings for WHWK's Other Working Capital Changes are $148000.0 (Q3 2025), $676000.0 (Q2 2025), and -$765000.0 (Q1 2025).